Skip to main content

Chickasaw Strategic Pointe, LLC wins $22m FDA Contract

  Return to News Section


Chickasaw Strategic Pointe, LLC (CSP), a subsidiary of Chickasaw Nation Industries, Inc. (CNI), has been awarded a $22 million contract to deliver pharmacovigilance systems implementation and IT lifecycle support for the FDA’s Adverse Event Reporting System (FAERS) II program.

“CNI is proud to partner with the FDA to help with the detection and reporting of adverse events,” said Eduardo Marques, President and COO of CNI’s Division of Civilian Services. “Our team of pharmacovigilance and HL7 data standards experts and technical professionals are truly dedicated to supporting this mission critical program.”

Chickasaw Strategic Pointe, LLC is set to begin work on this four year IDIQ contract in the first week of April.

Chickasaw Nation Industries, Inc. (CNI) is a federally chartered corporation wholly owned by the Chickasaw Nation. CNI’s Division of Civilian Services robust offerings include a wide range of IT and professional services and solutions in support of federal and state markets, as well as commercial entities. For more information about CNI, visit www.chickasaw.com